Navigation Links
Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China
Date:3/8/2011

LAKE ZURICH, Ill. and HONG KONG, March 8, 2011 /PRNewswire-Asia-FirstCall/ -- Fenwal Inc. of Lake Zurich, Illinois, and Golden Meditech Holdings Limited (stock code: 801.HK; 910801.TW) of Hong Kong announced today they have entered into a definitive agreement to form a joint venture in China that will sell advanced products and technologies for blood collection, storage and transfusion.

The joint venture is expected to be formed later this year after receiving customary commercial and regulatory approvals. The expected name of the new company will be Fenwal Jingjing Medical Technologies Ltd. (Fenwal Jingjing). Fenwal will own 51 percent of the new venture and Golden Meditech will own 49 percent.

Fenwal Jingjing will bring together advanced blood-collection, separation and storage technologies from both parent companies, and will benefit from the complementary strengths of Fenwal and Golden Meditech. Fenwal has a long history of innovation and leadership in blood technologies worldwide. Golden Meditech has expertise in serving China's unique and fast-growing health-care sector, with leadership in cord-blood banking and hospital services as well as medical-device development, manufacturing and distribution.

The joint venture will maintain an existing Fenwal office in Shanghai and establish a new operating subsidiary in Beijing, from which it will serve customers throughout China. Initially, Fenwal Jingjing will sell and distribute two key products: the Fenwal Amicus® blood-cell separator, a system used to collect platelets and other blood components such as stem cells; and the 3000H plasma exchange system, which removes toxins from the blood and was developed by a Golden Meditech subsidiary, Beijing Jingjing Medical Equipment Co. Ltd. The joint venture also will distribute related supplies and medical accessories to blood banks, cord blood banks and other medical institutions.

"Fenwal is a global pioneer and leader in advanced blood technologies," said Mr. Kam Yuen, Golden Meditech's chairman and chief executive officer. "Our combined strength and experience will facilitate the advancement of blood collection and transfusion medicine in China, while offering solutions that are tailored to the Chinese medical sector to better serve patients. This agreement is an important milestone and it's a great honor to forge this joint venture with such an excellent partner."

"Golden Meditech has quickly established a leading position in China for medical technologies and services," said Mr. Ron K. Labrum, Fenwal president and chief executive officer. "This is an important collaboration that expands our product offering, provides new resources for growth and innovation, and makes us a more attractive partner for other medical companies looking to enter into or accelerate growth in China."

The two companies had previously announced their intent to form a joint venture under a framework agreement signed in 2009.

About FenwalFenwal, Inc. is a global medical technology company dedicated to ensuring the continued availability, safety and effectiveness of blood - medicine's most vital natural resource. Fenwal offers the broadest range of products for the automated and manual collection, filtration, separation, storage and transfusion of blood and its components. The company was founded in 1949. Today, Fenwal products and advanced blood technologies are used to help treat patients on six continents. Fenwal, Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.

About Golden MeditechGolden Meditech Holdings Limited is China's leading integrated healthcare device and service provider, and the first medical device company that is publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx). Golden Meditech is a first-mover in China, having established leading positions in medical devices and healthcare services over the years, thanks to its strengths in innovation and commercial expertise and the ability to identify and realize emerging market opportunities. Going forward, the group will continue to pursue a leading position in niche market segments in China's healthcare industry both through organic growth and strategic expansion. For more information, please visit www.goldenmeditech.com.

Media Contacts:Fenwal

Golden MeditechTanya Tyska

Dennis Haikuan Lu+1-847-550-2732

+852-3605-8138tanya.tyska@fenwalinc.com

dennis@goldenmeditech.com
'/>"/>

SOURCE Golden Meditech; Fenwal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fenwal, GenesisBPS Enter Agreement for Blood-Specialty Products
2. Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business
3. Golden Meditech to Form Strategic Alliance with Long Bon International
4. Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
5. Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
6. Golden Meditech Announces Annual Results for FY 2009/10
7. Samplify Systems Completes Series B Funding
8. Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio
9. Amgen Completes Acquisition of BioVex
10. MicroConstants Completes Installation of Latest LC/MS/MS Technology to Achieve Improved Sensitivity in Bioanalytical Method Development
11. Elektas Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)...   Divoti USA will engrave and process ... of the latest FDA requirements, which stipulates new criteria regarding medical ... need of Medical ID jewelry such as Medical ID Bracelets, can ... in terms of the new FDA requirements . ... Divoti offers this dark mark fiber laser ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
Breaking Medicine News(10 mins):